Shots:
Hair loss (alopecia) is a condition that causes thinning or loss of hair on the scalp or the entire body. It can be temporary or permanent and may result from genetics, hormonal changes, medical issues, or aging
PharmaShots’ Disease of the Month report aims to educate a broad audience about health conditions that affect…
Shots:
Alkem Laboratories has launched Pertuza 420mg/14mL, a Perjeta biosimilar, across India for treating HER2-positive breast cancer
In a P-III trial, Pertuza showed equivalent efficacy, safety, and immunogenicity to the reference product
Pertuzumab is a HER2/neu receptor antagonist that was approved for HER2-positive breast cancer
Ref: Alkem Laboratories | Image: Alkem Laboratories | Press Release
Related News:- CuraTeQ Biologics Reports…
Shots:
Biogen has entered into a definitive agreement to acquire Alcyone Therapeutics, building on its partnership to advance ThecaFlex DRx
As per the deal, Biogen will acquire Alcyone Therapeutics for $85M upfront + potential milestone payments tied to the development & approval of ThecaFlex DRx with nusinersen & other products. The deal gives Biogen full…

